| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |